Pure Global

SEIMITSU Direct Bilirubin (D-BIL) - Indonesia BPOM Medical Device Registration

SEIMITSU Direct Bilirubin (D-BIL) is a medical device registered with Indonesia's BPOM (Badan Pengawas Obat dan Makanan) under Analysis ID AKL 20101024918. The device is manufactured by A CO., LTD. from Japan, and is classified as Risk Class Kelas Resiko : B. The authorized representative in Indonesia is PT. SEIMITSU DIAGNOSTICS.

This page provides comprehensive regulatory information including complete registration details, manufacturer information, authorized representative details, product classification, and related products. Pure Global AI offers free access to 67,600+ Indonesia medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
BPOM Registered
Risk Class Kelas Resiko : B
SEIMITSU Direct Bilirubin (D-BIL)
Analysis ID: AKL 20101024918

Risk Classification

Kelas Resiko : B

Product Class

Kelas : 2

Manufacturer

A CO., LTD.

Country of Origin

Japan

Authorized Representative

PT. SEIMITSU DIAGNOSTICS

AR Address

MAYAPADA TOWER LANTAI 11 JL. JEND. SUDIRMAN KAV.28

Registration Date

Jul 11, 2023

Expiry Date

Jun 10, 2025

Product Type

Clinical Chemistry Test System

Bilirubin (total or direct) test system (kit & cair)

Invitro Diagnostics

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing